Skip to main content
Kontour(Xi'an) Medical Technology Co., Ltd. logo

Kontour(Xi'an) Medical Technology Co., Ltd. — Investor Relations & Filings

Ticker · 688314 ISIN · CNE1000077Y8 Shanghai Stock Exchange Manufacturing
Filings indexed 455 across all filing types
Latest filing 2026-05-20 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688314

About Kontour(Xi'an) Medical Technology Co., Ltd.

http://www.kontourmedical.com.cn/

Kontour (Xi'an) Medical Technology Co., Ltd. specializes in the research, development, and manufacturing of advanced medical devices for neurosurgery and craniofacial reconstruction. The company focuses on high-performance materials, particularly PEEK (Polyetheretherketone) and titanium, to produce cranial implants, fixation systems, and surgical instruments. Its core offerings include patient-specific PEEK implants designed through 3D modeling for precise anatomical fit, as well as titanium mesh and bone plates for skull repair and stabilization. Kontour provides comprehensive clinical solutions for treating cranial defects, trauma, and deformities, emphasizing biocompatibility and structural integrity. The firm maintains a focus on Class III medical device innovation to support complex reconstructive procedures in the global healthcare market.

Recent filings

Filing Released Lang Actions
西安康拓医疗技术股份有限公司股票交易严重异常波动公告
Regulatory Filings Classification · 88% confidence The text is an official public announcement by the company’s board regarding a serious abnormal fluctuation in its stock price under Shanghai Stock Exchange rules. It is a mandatory regulatory disclosure without substantive financial statements or performance data, and does not fit into more specific categories like earnings, dividends, or M&A. Therefore it falls under the general “Regulatory Filings” category.
2026-05-20 Chinese
西安康拓医疗技术股份有限公司关于变更持续督导保荐代表人的公告
Regulatory Filings Classification · 80% confidence The document is a corporate announcement by the board of Xi’an Kontuo Medical Technology Co., Ltd. (证券简称:康拓医疗) disclosing a change in its continuous supervision sponsor representative appointed by its underwriting institution. It contains neither financial statements nor a formal report, nor is it an internal board or management appointment of the company itself; rather it is a routine regulatory disclosure required by the exchange. It does not fit specialized categories such as Capital/Financing Update, Director’s Dealing, or M&A Activity. Therefore, it falls under the fallback category for miscellaneous regulatory filings.
2026-05-11 Chinese
西安康拓医疗技术股份有限公司关于参加2026年陕西辖区上市公司投资者集体接待日暨2025年度业绩说明会的公告
Regulatory Filings Classification · 78% confidence The document is a corporate announcement (“公告”) regarding the company’s participation in a collective investor reception day and performance explanation meeting, with no actual financial statements or detailed investor presentation materials attached. It’s an event notice published on the exchange, not a full report (10-K, IR), not a proxy statement, dividend notice, or call transcript, and it simply informs investors of an upcoming investor engagement. This falls under general regulatory announcements that don’t fit a more specific category, so it is classified as RNS.
2026-05-11 Chinese
西安康拓医疗技术股份有限公司关于公司股东权益变动触及1%刻度的提示性公告
Major Shareholding Notification Classification · 100% confidence The document is a notification about a change in shareholding percentage by a major shareholder and its related parties. It details the decrease in shareholding by a controlling shareholder and confirms that the change does not trigger mandatory tender offer obligations. The document includes specific shareholding percentages before and after the change, the method of share disposal, and references to compliance with securities laws and disclosure requirements. It is a typical major shareholding notification informing the market about crossing a 1% threshold in shareholding changes. The document is not a full financial report, earnings release, or management discussion, nor is it an announcement of a meeting or voting results. It fits the category of Major Shareholding Notification (MRQ).
2026-05-08 Chinese
西安康拓医疗技术股份有限公司2025年年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is titled '2025年年度权益分派实施公告' which translates to '2025 Annual Equity Distribution Implementation Announcement'. It details the dividend distribution plan for the 2025 fiscal year, including dividend per share, relevant dates (record date, ex-dividend date, payment date), tax treatment for different shareholder categories, and the approval of the distribution plan at the 2026 shareholders meeting. The document is an announcement of dividend amount and payment details rather than a full financial report or earnings release. It is relatively short (2000 characters) and focuses solely on dividend distribution information. Therefore, it fits the category of 'Notice of Dividend Amount' (DIV).
2026-05-06 Chinese
西安康拓医疗技术股份有限公司关于向激励对象授予预留部分限制性股票的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the granting of reserved restricted shares under a 2025 restricted stock incentive plan by Xi'an Kangtuo Medical Technology Co., Ltd. It details the decision-making process, approval by the board and shareholders, the number of shares granted, the recipients, the grant price, and the accounting treatment of the stock incentive. The document is a formal public announcement of a share-based incentive plan grant to employees and management, including directors. It does not contain financial statements or quarterly/annual financial results, nor is it a transcript or presentation. It is not a report publication announcement since it contains substantive details about the share grant. The content fits the category of a Capital/Financing Update (CAP) because it relates to changes in the company's capital structure through issuance of restricted shares as part of an employee incentive plan.
2026-04-28 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.